Looks like the Holiday season is finishing early this year especially for our politicians and also judging on the flurry of news reaching us in the last two weeks. However the “silly season” prevails with September’s Which? report supposedly highlighting a number of practices failings in providing good advice to researchers. The College and the Confederation respond separately although in similar vein.
The decisions were made by a secret panel of 3 advisors so the profession is not to know of their depth of understanding of practice optometric issues. Maybe they should declare themselves, and really earn their money.
We report on a major funding boost for Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology and how Moorfields is looking for family linked glaucoma sufferers for a gene test.
Allders Opticians in Herts announces a new concept complete refit by its industry owners.
Action for Blind People has prepared an interesting and informative document on “How best to approach and help the blind get around”
The BCLA announces the return of its highly popular Workshops, non members on payment can now attend. We list October’s titles.
One of PHN’s Directors, Bob Hutchinson, has been invited and elected on to the Council for General Practice and Primary Health Care, the largest section of the Royal Society of Medicine’s members with among its membership over 12,000 GPs. Hutchinson comments on his aspirations for his time on the Council.
Uvex, through Rodenstock, announces a new sporty ophthalmic range modeled by the German Mountain Bike champion Karl Platt, and Porsche Design announce their latest models.
Grafton Optical reveal their summer specials, available until 30th September or while stock last.
First to provide information this year for Silmo 2011 is Oliver Goldsmith with their latest collection. Are there more UK companies with products to highlight?
Finally, don't forget to join all those already following us on twitter to get even more from the site - www.twitter.com/primaryhealthnt.
No comments:
Post a Comment